Drug Trial Radar · NCT04294862
Tissue Distribution, Pharmacokinetics, Safety, and Tolerability After a Single Dose of TNP-2092 in Participants Undergoing Primary Total Hip or Knee Arthroplasty
Last checked: Nov 20, 2026Latest source record: Oct 19, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
Mar 1, 2021
Primary completion
Dec 31, 2021
Study completion Jun 29, 2022
Sponsor
- Lead sponsor
- TenNor Therapeutics LimitedIndustry
- Sponsor type
- Industry
- First posted
- Mar 4, 2020
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will investigate TNP-2092 distribution into joint tissues in participants undergoing a total hip arthroplasty (THA) or a total knee arthroplasty (TKA). Tissue distribution is the primary objective, and plasma pharmacokinetics (PK), safety, and tolerability are secondary objectives.
Conditions
- Prosthetic Joint Infection
Interventions
TNP-2092Drug
TNP-2092 for injection 100mg/vial
Primary outcomes
What the sponsor says the trial is designed to measure.
- Concentration of TNP-2092 in synovial fluidTime frame: 2 hours after infusion
- Concentration of TNP-2092 in boneTime frame: 2 hours after infusion
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Rothman Orthopedic Institute
Philadelphia, Pennsylvania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.